BridgeMD
New treatment option for Binge-Eating Disorder
Official title Study of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder
ClinicalTrials.gov ID: NCT06864065
What this study is testing
- What it's testing
- The goal of this exploratory, interventional, multicentre study is to compare the prefrontal activity during a negative emotion regulation task in women with Binge-Eating Disorder (BED) and healthy women with and without Emotional Eating (EE). The aim of this study is to compare the prefrontal processing of cognitive control of emotions between BED and EE and to compare the emotional processing and emotional experience between BED and EE.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60, women only. Healthy volunteers may be eligible.
You may be able to join if
- Women between 18 and 60 years old (including 60)
- Right-handed.
- For patients only : diagnosed with Binge Eating Desordors according to DSM criteria.
- Membership of a French social security scheme or beneficiary of such a scheme.
- Non-opposition of the subject to participate in the study. Non Healthy volunteers only :
See the full eligibility criteria
- Women between 18 and 60 years old (including 60)
- Right-handed.
- For patients only : diagnosed with Binge Eating Desordors according to DSM criteria.
- Membership of a French social security scheme or beneficiary of such a scheme.
- Non-opposition of the subject to participate in the study. Non Healthy volunteers only :
- Suffering from an eating disorder or any other psychiatric disorder.
- History of bariatric surgery. All people (healthy volunteers and patients) :
- Rare obesity (genetic or syndromic).
- Specific addictions (substances or behaviors).
- Neurological disorders and/or history of stroke or head trauma.
- Presence of lesions, wounds or dermatitis at the sites where the recording devices are applied.
- Any serious acute or chronic illness other than the pathology under study, or any treatment likely to interfere with the evaluation of the parameter under study.
- Inability to follow protocol requirements.
- Subject unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator.
- Subject unable to speak French and/or unable to read.
- Pregnant or breast-feeding women.
- Persons deprived of their liberty by judicial or administrative decision; persons under compulsory psychiatric care; persons admitted to a health or social institution for purposes other than research.
The study team makes the final eligibility decision.
Where it's taking place
- Besançon, France
- Dijon, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Besançon, France; Dijon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.